The effect of orally and of intravenously administered stable strontium on90 Sr metabolism was investigated in man under strictly controlled dietary conditions. The oral dose of stable strontium averaging 1517 mg/day was given as the lactate for 24-48 days. Intravenous infusions of stable strontium as the gluconate were given in 500 ml 5% glucose in water over 4 hours on 6 consecutive days. The amounts of stable strontium infused per day were 318, 612, 954, and 1200 mg, respectively.90 Sr and calcium balances were determined before and during the oral and intravenous administration of stable strontium. Stable strontium given orally or intravenously increased the urinary90 Sr excretion. This increase was greater when stable strontium was given intravenously than orally, the average factor of increase being 3 and 1.65 in the two studies, respectively. The fecal90 Sr excretions did not increase during either oral or intravenous administration of stable strontium. The90 Sr balances changed little during the oral intake of stable strontium while they became more negative during the infusions of stable strontium. The urinary calcium increased during the oral or intravenous administration of stable strontium and this increase was greater when stable strontium was given intravenously than orally.
Skip Nav Destination
Close
Article navigation
1 July 1972
Research Article|
July 01 1972
Effect of Orally and Intravenously Administered Stable Strontium on90 Sr Metabolism in Man
Radiat Res (1972) 51 (1): 190–203.
Citation
Herta Spencer, Joseph Samachson, Edward P. Hardy,, Joseph Rivera; Effect of Orally and Intravenously Administered Stable Strontium on90 Sr Metabolism in Man. Radiat Res 1 July 1972; 51 (1): 190–203. doi: https://doi.org/10.2307/3573654
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner